GEXVal Selected as Finalist for CITELINE JAPAN AWARDS 2024 in Categories: EXECUTIVE OF THE YEAR & FINANCING DEAL OF THE YEAR

GEXVal Inc.
October 8, 2024

 

We are honored to announce that GEXVal Inc. (President and CEO: Juran Kato, PhD; Location: Fujisawa, Kanagawa, Japan) and our company's representative have been selected as finalists in two categories of the CITELINE JAPAN AWARDS 2024: FINANCING DEAL OF THE YEAR and EXECUTIVE OF THE YEAR, respectively. The award winners will be announced on October 22nd at The Palace Hotel, Tokyo, Japan.

For more information about the event, including a list of finalists in each category, please visit the official CITELINE JAPAN AWARDS website. Please note that pre-registration is required to attend the event. There is no fee for entering.
Website: https://www.citeline.com/en/awards/citelinejapanawards

The CITELINE JAPAN AWARDS 2024 is the Japanese counterpart of the Scrip Awards (Scrip Awards 2024 | Citeline) , a global recognition event that has been held in the UK for nearly 20 years. It is a prestigious event that celebrates excellence and innovation among companies and individuals in the pharmaceutical and biotechnology industries in Japan and the Asia-Pacific region.

Mr. Keiichi Kiyota, our Chief Financial Officer, stated, "We are honored to be selected as finalists and look forward to celebrating this special occasion alongside other industry leaders."

 

For further information:
Head of Corporate office
Atsushi Sugizaki
info@gexval.com